Bristol Myers Squibb Co. (BMY)
62.48
+1.09
(+1.78%)
USD |
NYSE |
Oct 30, 16:00
62.55
+0.07
(+0.11%)
Pre-Market: 20:00
Bristol Myers Squibb 30-Day Average Daily Volume : 12.72M for Oct. 30, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 30, 2026 | 12.72M |
| October 29, 2026 | 13.52M |
| October 28, 2026 | 13.44M |
| October 27, 2026 | 13.50M |
| October 26, 2026 | 13.58M |
| October 23, 2026 | 13.55M |
| October 22, 2026 | 13.46M |
| October 21, 2026 | 13.17M |
| October 20, 2026 | 13.09M |
| October 19, 2026 | 13.01M |
| October 16, 2026 | 12.78M |
| October 15, 2026 | 12.53M |
| October 14, 2026 | 12.33M |
| October 13, 2026 | 12.10M |
| October 12, 2026 | 11.95M |
| October 09, 2026 | 11.39M |
| October 08, 2026 | 11.23M |
| October 07, 2026 | 11.05M |
| October 06, 2026 | 10.94M |
| October 05, 2026 | 10.84M |
| October 02, 2026 | 10.43M |
| October 01, 2026 | 10.41M |
| September 30, 2026 | 10.51M |
| September 29, 2026 | 10.30M |
| September 28, 2026 | 10.01M |
| Date | Value |
|---|---|
| September 25, 2026 | 9.798M |
| September 24, 2026 | 9.794M |
| September 23, 2026 | 9.547M |
| September 22, 2026 | 9.331M |
| September 21, 2026 | 9.148M |
| September 18, 2026 | 9.161M |
| September 17, 2026 | 8.251M |
| September 16, 2026 | 8.314M |
| September 15, 2026 | 8.776M |
| September 14, 2026 | 9.542M |
| September 11, 2026 | 9.798M |
| September 10, 2026 | 10.16M |
| September 09, 2026 | 10.30M |
| September 08, 2026 | 10.59M |
| September 04, 2026 | 10.61M |
| September 03, 2026 | 10.85M |
| September 02, 2026 | 10.90M |
| September 01, 2026 | 10.87M |
| August 31, 2026 | 10.89M |
| August 28, 2026 | 10.81M |
| August 27, 2026 | 11.03M |
| August 26, 2026 | 11.22M |
| August 25, 2026 | 11.38M |
| August 24, 2026 | 11.59M |
| August 21, 2026 | 11.76M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Johnson & Johnson | 7.270M |
| Eli Lilly & Co. | 2.448M |
| Merck & Co., Inc. | 9.901M |
| Pfizer Inc. | 30.18M |
| AstraZeneca PLC | 2.950M |